Related references
Note: Only part of the references are listed.A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
S. De Vita et al.
ARTHRITIS AND RHEUMATISM (2012)
Genetic Determinants in Hepatitis C Virus-Associated Mixed Cryoglobulinemia: Role of Polymorphic Variants of BAFF Promoter and Fcγ Receptors
Laura Gragnani et al.
ARTHRITIS AND RHEUMATISM (2011)
Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type
Marc Ittah et al.
JOURNAL OF INNATE IMMUNITY (2011)
Interferon-beta increases systemic BAFF levels in multiple sclerosis without increasing autoantibody production
Chris J. Hedegaard et al.
MULTIPLE SCLEROSIS JOURNAL (2011)
Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study
Franco Dammacco et al.
BLOOD (2010)
Serum cytokine profile in hepatitis C virus carriers presenting cryoglobulinaemia and non-organ-specific autoantibodies
Ajax M. Atta et al.
MICROBIAL PATHOGENESIS (2010)
Genetic Variation in B-Cell-Activating Factor Is Associated with an Increased Risk of Developing B-Cell Non-Hodgkin Lymphoma
Anne J. Novak et al.
CANCER RESEARCH (2009)
Serum BLyS/BAFF predicts the outcome of acute hepatitis C virus infection
G. Tarantino et al.
JOURNAL OF VIRAL HEPATITIS (2009)
BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
Valeriya Zarkhin et al.
TRANSPLANTATION (2009)
The Evolutionary Dynamics of a Rapidly Mutating Virus within and between Hosts: The Case of Hepatitis C Virus
Fabio Luciani et al.
PLOS COMPUTATIONAL BIOLOGY (2009)
Direct B cell stimulation by dendritic cells in a mouse model of lupus
Suigui Wan et al.
ARTHRITIS AND RHEUMATISM (2008)
Can BAFF promoter polymorphism be a predisposing condition for HCV-related mixed cryoglobulinemia?
Carlo Giannini et al.
BLOOD (2008)
Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways
Marc Ittah et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
BAFF is a biological response marker to IFN-β treatment in multiple sclerosis
Kaushal S. Gandhi et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2008)
Substitution rate of the hepatitis B virus surface gene
H. L. Zaaijer et al.
JOURNAL OF VIRAL HEPATITIS (2008)
Cryoglobulinemia-related vasculitis during effective anti-HCV treatment with PEG-interferon alfa-2b
T. De Blasi et al.
INFECTION (2008)
Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production
Frederic Lavie et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Hepatitis C virus-associated B-cell proliferation - the role of serum B lymphocyte stimulator (BLyS/BAFF)
D. Sene et al.
RHEUMATOLOGY (2007)
Elevated serum B-lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity
E. Toubi et al.
JOURNAL OF AUTOIMMUNITY (2006)
Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders
AJ Novak et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Differential effects on BAFF and APRIL levels in rituximab-treated patients with systemic lupus erythematosus and rheumatoid arthritis
Therese Vallerskog et al.
ARTHRITIS RESEARCH & THERAPY (2006)
B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjogren's syndrome
Marc Ittah et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Vasculitic complications of interferon-a treatment for chronic hepatitis C virus infection: case report and review of the literature
W Beuthien et al.
CLINICAL RHEUMATOLOGY (2005)
BAFF augments certain Th1-associated inflammatory responses
APR Sutherland et al.
JOURNAL OF IMMUNOLOGY (2005)
BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma
M Krumbholz et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Reduced competitiveness of autoantigen-engaged B cells due to increased dependence on BAFF
R Lesley et al.
IMMUNITY (2004)
Sustained exacerbation of cryoglobulinaemia-related vasculitis following treatment of hepatitis C with peginterferon alfa
D Batisse et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2004)
Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches
M Thien et al.
IMMUNITY (2004)
Analysis on the association of human BLYS (BAFF TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis
A Kawasaki et al.
GENES AND IMMUNITY (2002)
Pathogenesis and natural history of osteonecrosis
Y Assouline-Dayan et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.
MW Fried et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Th1/Th2 cytokine imbalance in patients with Sjogren syndrome secondary to hepatitis C virus infection
M Ramos-Casals et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2002)
The lymphoid system in hepatitis C virus infection: Autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy
F Dammacco et al.
SEMINARS IN LIVER DISEASE (2000)